Chen et al. (2017) reported that the lncRNA CRNDE promotes angiogenesis in HBs by targeting the miR-203/VEGFA axis, suggesting that this pathway plays an important regulatory role in the occurrence and development of HBs, laying the foundation for new tumor biomarkers and therapeutic targets for HB diagnosis and treatment. Here, VEGFA is linked to neoplasm.